Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03836521 · ClinicalTrials.gov registry record
Bicuspid Aortic Valve Stenosis Transcatheter Aortic Valve Replacement Registry
A clinical trial of Bicuspid Aortic Valve, sponsored by Cedars-Sinai Medical Center.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT03836521 is a study of Bicuspid Aortic Valve that is actively recruiting participants, run by Cedars-Sinai Medical Center. The registered enrollment target is 2,000 participants, below the 2,350-participant average among 4 other Bicuspid Aortic Valve trials with a reported enrollment target (15% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03836521, a study of Bicuspid Aortic Valve, is actively recruiting participants, sponsored by Cedars-Sinai Medical Center.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to evaluate the procedural and clinical outcomes of patients with bicuspid aortic valve stenosis undergoing transcatheter aortic valve replacement.
Conditions Studied
Interventions
- DEVICE Transcatheter aortic valve replacement
Study Locations (1)
California
- Cedars-Sinai Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2016-08-15 |
| Est. Completion | 2028-08-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03836521
The ClinicalTrials.gov registry entry for NCT03836521 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,350-participant average among 4 other Bicuspid Aortic Valve trials with a reported enrollment target (15% lower). The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bicuspid Aortic Valve appearing as the primary indexed condition, and to 1 intervention - of which Transcatheter aortic valve replacement is the first listed.
NCT03836521 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03836521 about?
NCT03836521 is a clinical study titled "Bicuspid Aortic Valve Stenosis Transcatheter Aortic Valve Replacement Registry". The objective of this study is to evaluate the procedural and clinical outcomes of patients with bicuspid aortic valve stenosis undergoing transcatheter aortic valve replacement.
What is the current status of trial NCT03836521?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2016-08-15. Estimated completion is 2028-08-15.
What conditions does trial NCT03836521 study?
This clinical trial studies the following conditions: Bicuspid Aortic Valve.
What interventions are being tested in trial NCT03836521?
The interventions under investigation include: Transcatheter aortic valve replacement (DEVICE).
Who is sponsoring clinical trial NCT03836521?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03836521 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bicuspid Aortic Valve
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Bicuspid Aortic Valve (BAV) Registry
RECRUITING
-
Bicuspid Aortic Valve Replacement: Evaluation of Transcatheter Versus Surgery-Pilot Trial
RECRUITING · NA
-
Identification of Genetic Causes of Bicuspid Aortic Valve Disease
ACTIVE NOT RECRUITING
-
Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.